CVS Health Corp (NYSE:CVS) shares were weak in pre-market trading after the drugstores operator cuts its full-year earnings guidance despite reporting second-quarter earnings and revenue ahead of estimates. The institutional investor owned 88,732 shares of the pharmacy operator's stock after selling 1,775 shares during the period. CA's portfolio, making the stock its 3rd largest position. The stock increased 1.47% or $1.15 during the last trading session, reaching $79.12.
Depending on the earnings numbers reported, CVS Health Corporation (NYSE:CVS) stock may see increased volatility following the report. The stock has decreased 19 percent in the last 12 months. D Orazio & Associates Inc. raised its stake in CVS Health Corporation by 34.5% in the fourth quarter. Franklin Resources Inc. now owns 14,288,826 shares of the pharmacy operator's stock worth $1,127,532,000 after buying an additional 2,372,019 shares during the period. Finally, Elgethun Capital Management purchased a new stake in CVS Health Corporation during the fourth quarter valued at approximately $133,000.
Minnesota's attorney general has also sought information from it regarding a probe into pricing of insulin and epinephrine drugs, CVS Health said. The Callahan Advisors Llc holds 51,723 shares with $4.08M value, down from 55,737 last quarter.
Vantage Investment Advisors Llc, which manages about $916.05M and $246.41M US Long portfolio, upped its stake in Comcast Corporation A (NASDAQ:CMCSA) by 83,986 shares to 90,196 shares, valued at $6.23M in 2016Q4, according to the filing.
CVS Health exited the quarter with cash and cash equivalents and short-term investments of $2.2 billion compared with $2.3 billion at the end of first-quarter 2017. RDNT's distance from 20 day simple moving average is 4.95% and distance from 50-Day simple moving average is 5.88%. The Company has 52-week high of $98.44 and 52-week low of $69.30. It looks like traders are not happy with the stock.
The Relative Volume of the company is 1.04 and Average Volume (3 months) is 5.83 million.
Now the shares of CVS Health Corporation (CVS) has the trading volume of 6.05 Million shares with the average trading volume of 4650 shares. They expect $1.31 earnings per share, down 0.76% or $0.01 from last year's $1.32 per share. Raymond James Finance Advisors reported 0.23% in CVS Health Corp (NYSE:CVS). During the same period previous year, the company earned $1.32 earnings per share. The company had revenue of $45.69 billion during the quarter, compared to the consensus estimate of $45.36 billion. Stockholders of record on Monday, July 24th were paid a dividend of $0.50 per share. (NYSE:DLR) were released by: Nasdaq.com and their article: "Digital Realty (DLR) to Post Q2 Earnings: What's in Store?" published on July 24, 2017 as well as Prnewswire.com's news article titled: "Digital Realty Announces Pricing of Pounds Sterling-Denominated Guaranteed Notes" with publication date: July 12, 2017.
Pharmacy same-store sales dropped 2.8% and saw a 410 basis point impact of new generic introductions, with same-store prescription volumes remaining flat on a 30-day equivalent basis. CVS Health Corporation's dividend payout ratio (DPR) is presently 41.67%.
ILLEGAL ACTIVITY WARNING: This story was first reported by Transcript Daily and is the property of of Transcript Daily. If you are reading this report on another website, it was illegally stolen and republished in violation of US & global copyright law.
Azimuth Capital Management Llc increased Henkel Ag & Co Kgaa (HENOY) stake by 13,700 shares to 26,860 valued at $3.21M in 2016Q4.
CVS has been the subject of several research analyst reports. The stock of CVS Health Corp (NYSE:CVS) has "Hold" rating given on Friday, June 9 by Jefferies. Finally, Cowen and Company restated an outperform rating and issued a $86.00 price objective on shares of CVS Health Corporation in a research note on Tuesday, June 13th. Tigress Financial initiated the shares of CVS in report on Friday, April 28 with "Buy" rating. Cohen & Steers Inc holds 0.03% in CVS Health Corp (NYSE:CVS) or 143,638 shares. The short ratio in the company's stock is documented at 4.6 and the short float is around of 2.64%. Argus Research maintained the stock with "Buy" rating in Monday, August 10 report.
When it comes to the Analysis of a Stock, Price Target plays a vital role.
In other news, EVP Helena Foulkes sold 20,333 shares of CVS Health Corporation stock in a transaction on Monday, June 26th. The stock was sold at an average price of $76.98, for a total value of $1,565,157.36. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The insider Denton David M sold 230,510 shares worth $18.44 million. Following the completion of the sale, the chief financial officer now directly owns 176,983 shares in the company, valued at $14,158,640. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 271,175 shares of company stock worth $21,632,597. The stock decreased 0.80% or $0.63 on August 4, reaching $77.97.
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.